RadNet, Inc. (RDNT) stock
RDNTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/3056% above fair value
$76.42+0.38 (+0.50%)
Close on Nov 13, 2026Market cap $6.01BP/E –Yield –
RadNet cash
Cash and short-term investments held at the end of each period.
RadNet's cash was $750.61M at Sep 30, 2026. For fiscal 2025 it was $767.22M, up 3.7% from the year before. Over ten years it grew 110.6% a year on average. The highest annual figure on record is $767.22M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $767.22M | +3.7% |
| FY2024 | Dec 31, 2024 | $740.02M | +116.0% |
| FY2023 | Dec 31, 2023 | $342.57M | +168.0% |
| FY2022 | Dec 31, 2022 | $127.83M | -5.0% |
| FY2021 | Dec 31, 2021 | $134.61M | +31.9% |
| FY2020 | Dec 31, 2020 | $102.02M | +154.0% |
| FY2019 | Dec 31, 2019 | $40.17M | +286.6% |
| FY2018 | Dec 31, 2018 | $10.39M | -79.8% |
| FY2017 | Dec 31, 2017 | $51.32M | +148.7% |
| FY2016 | Dec 31, 2016 | $20.64M | +4527.4% |
| FY2015 | Dec 31, 2015 | $446.00K | +45.3% |
| FY2014 | Dec 31, 2014 | $307.00K | +6.6% |
| FY2013 | Dec 31, 2013 | $288.00K | -83.8% |
| FY2012 | Dec 31, 2012 | $1.78M | -14.9% |
| FY2011 | Dec 31, 2011 | $2.09M | +15.5% |
| FY2010 | Dec 31, 2010 | $1.81M | +24.2% |
| FY2009 | Dec 31, 2009 | $1.46M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $750.61M | -6.7% |
| Q2 FY2026 | Jun 30, 2026 | $726.27M | -12.8% |
| Q1 FY2026 | Mar 31, 2026 | $455.34M | -36.5% |
| Q4 FY2025 | Dec 31, 2025 | $767.22M | +3.7% |
| Q3 FY2025 | Sep 30, 2025 | $804.72M | +7.5% |
| Q2 FY2025 | Jun 30, 2025 | $833.15M | +12.3% |
| Q1 FY2025 | Mar 31, 2025 | $717.32M | +36.1% |
| Q4 FY2024 | Dec 31, 2024 | $740.02M | +116.0% |
| Q3 FY2024 | Sep 30, 2024 | $748.92M | +121.6% |
| Q2 FY2024 | Jun 30, 2024 | $741.68M | +108.0% |
| Q1 FY2024 | Mar 31, 2024 | $526.98M | +480.1% |
| Q4 FY2023 | Dec 31, 2023 | $342.57M | +168.0% |
| Q3 FY2023 | Sep 30, 2023 | $337.88M | +255.6% |
| Q2 FY2023 | Jun 30, 2023 | $356.65M | +259.6% |
| Q1 FY2023 | Mar 31, 2023 | $90.84M | +28.5% |
| Q4 FY2022 | Dec 31, 2022 | $127.83M | -5.0% |
| Q3 FY2022 | Sep 30, 2022 | $95.01M | -37.2% |
| Q2 FY2022 | Jun 30, 2022 | $99.17M | -29.6% |
| Q1 FY2022 | Mar 31, 2022 | $70.71M | +127.4% |
| Q4 FY2021 | Dec 31, 2021 | $134.61M | +31.9% |
| Q3 FY2021 | Sep 30, 2021 | $151.25M | +70.4% |
| Q2 FY2021 | Jun 30, 2021 | $140.85M | +66.5% |
| Q1 FY2021 | Mar 31, 2021 | $31.09M | -67.0% |
| Q4 FY2020 | Dec 31, 2020 | $102.02M | +154.0% |
| Q3 FY2020 | Sep 30, 2020 | $88.74M | +135.5% |
| Q2 FY2020 | Jun 30, 2020 | $84.58M | +177.3% |
| Q1 FY2020 | Mar 31, 2020 | $94.28M | +804.1% |
| Q4 FY2019 | Dec 31, 2019 | $40.17M | +286.6% |
| Q3 FY2019 | Sep 30, 2019 | $37.69M | +38.4% |
| Q2 FY2019 | Jun 30, 2019 | $30.50M | +87.7% |
| Q1 FY2019 | Mar 31, 2019 | $10.43M | -70.2% |
| Q4 FY2018 | Dec 31, 2018 | $10.39M | -79.8% |
| Q3 FY2018 | Sep 30, 2018 | $27.23M | +221.5% |
| Q2 FY2018 | Jun 30, 2018 | $16.25M | +27.9% |
| Q1 FY2018 | Mar 31, 2018 | $35.04M | +322.5% |
| Q4 FY2017 | Dec 31, 2017 | $51.32M | +148.7% |
| Q3 FY2017 | Sep 30, 2017 | $8.47M | – |
| Q2 FY2017 | Jun 30, 2017 | $12.71M | – |
| Q1 FY2017 | Mar 31, 2017 | $8.29M | – |
| Q4 FY2016 | Dec 31, 2016 | $20.64M | – |
See a number that looks wrong?